New research suggests that a person’s overall physical and mental abilities, known as intrinsic capacity, may help predict ...
Review shows no significant association between MHT and risk for MCI or dementia, with no significant effects in subgroup analyses.
Neurocognitive disorders, mild and major, include a group of conditions which were once all grouped under the umbrella term “dementia.” The conditions involve similar cognitive impairments and decline ...
Menopause hormone therapy neither increases nor decreases the risk for dementia or mild cognitive impairment in ...
But dementia isn’t inevitable if you’ve been clinically diagnosed with MCI. According to some studies, only about 30 percent of people with MCI progress to dementia after five years. Talk to your ...
Cognitive decline poses unique risks to family businesses. Learn essential planning strategies beyond wills to protect ...
Wednesday, Sage Therapeutics Inc (NASDAQ:SAGE) announced topline results from the PRECEDENT Phase 2 study of dalzanemdor (SAGE-718) in people with mild cognitive impairment in Parkinson’s Disease. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback